Molecular mechanism in urothelial carcinoma with FGFR3 mutation.

被引：0
|
作者：
Liu, Huanhuan [1 ]
Zhang, Yanrui [1 ]
Lou, Feng [1 ]
Cao, Shanbo [1 ]
Wang, Huina [1 ]
机构：
[1] Acornmed Biotechnol Co Ltd, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16548
引用
收藏
页码：E16548 / E16548
页数：1
相关论文
共 50 条
  • [1] Combination of Urine Cytology and FGFR3 Mutation for the Diagnosis of Urothelial Carcinoma
    Gao, L.
    Reddy, P. L.
    Joseph, L.
    Antic, T.
    Mueller, J.
    Khan, G.
    Torres, M.
    DeMay, R.
    Reeves, W.
    LABORATORY INVESTIGATION, 2012, 92 : 90A - 90A
  • [2] Combination of Urine Cytology and FGFR3 Mutation for the Diagnosis of Urothelial Carcinoma
    Gao, L.
    Reddy, P. L.
    Joseph, L.
    Antic, T.
    Mueller, J.
    Khan, G.
    Torres, M.
    DeMay, R.
    Reeves, W.
    MODERN PATHOLOGY, 2012, 25 : 90A - 90A
  • [3] Achondroplasia phenotype due to novel FGFR3 mutation.
    Zabel, BU
    Hilbert, K
    Beck, M
    Stelzer, C
    Wildhardt, G
    Winterpacht, A
    Spranger, J
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 388 - 388
  • [4] FGFR3 mutation is not the initiating mutation in Urothelial Cell Cancer
    Ahmad, I.
    Iwata, T.
    Wu, X. R.
    Leung, H. Y.
    Sansom, O. J.
    BJU INTERNATIONAL, 2009, 103 : 18 - 18
  • [5] Validation of FGFR3 immunohistochemistry as a predictor of FGFR3 genetic alterations in urothelial carcinoma
    Lopez Del Campo, R.
    Mercader, C.
    Calderon, R.
    Albaiges, J.
    Ferrer-Mileo, L.
    Ribera-Cortada, I.
    Trias, I.
    Vilaseca, A.
    Rodriguez-Carunchio, L.
    VIRCHOWS ARCHIV, 2024, 485 : S172 - S172
  • [6] Mutation of FGFR3 in transitional cell carcinoma
    Sibley, K
    Kennedy, W
    Knowles, M
    BRITISH JOURNAL OF CANCER, 2001, 85 : 79 - 79
  • [7] Update on FGFR3 mutation and MRES phenotype in urothelial carcinogenesis
    Masson-Lecomte, A.
    Vordos, D.
    de la Taille, A.
    Neuzillet, Y.
    Radvanyi, F.
    Allory, Y.
    PROGRES EN UROLOGIE, 2013, 23 (02): : 96 - 98
  • [8] FGFR3 MUTATION ASSOCIATES WITH IMPROVED CANCER SPECIFIC OUTCOME IN UPPER TRACT UROTHELIAL CARCINOMA
    Sfakianos, John P.
    Cha, Eugene K.
    Kim, Philip H.
    Iyer, Gopa
    Hakimi, A. A.
    Scott, Sasinya N.
    Ramirez, Ricardo
    Hanrahan, Aphrothiti J.
    Rosenberg, Jonathan E.
    Ren, Qinghu
    Al-Ahmadie, Hikmat
    Dalbagni, Guido
    Bajorin, Dean F.
    Berger, Michael F.
    Bochner, Bernard H.
    Solit, David B.
    Coleman, Jonathan A.
    JOURNAL OF UROLOGY, 2014, 191 (04): : E920 - E920
  • [9] Exceptional Response to Pazopanib in a Patient with Urothelial Carcinoma Harboring FGFR3 Activating Mutation and Amplification
    Palma, Norma
    Morris, John C.
    Ali, Siraj M.
    Ross, Jeffrey S.
    Pal, Sumanta Kumar
    EUROPEAN UROLOGY, 2015, 68 (01) : 168 - 170
  • [10] FGFR3 protein expression and gene mutation in primary and metastatic urothelial carcinoma (UC) tumors
    Rosenberg, Jonathan E.
    Werner, Lillian
    Bamias, Aristotelis
    Choueiri, Toni K.
    Schutz, Fabio A. B.
    Park, Rachel S.
    O'Brien, Robert
    Guancial, Elizabeth Ann
    Ross, Robert W.
    Berman, David M.
    Riester, Markus
    Lis, Rosina
    Loda, Massimo F.
    Stack, Edward C.
    Michor, Franziska
    Chehab, Nabil
    Molins, Joaquim Bellmunt
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345